RRRC logo
|| Home || About RRRC || Contact Us ||   

Accepted Strains
Not Currently Available for Distribution

The list below includes strains that have been accepted into the Center and are in the process of being acquired but are currently not available for distribution.

Please indicate your interest in obtaining any of the strains by clicking the checkbox (column "Select") next to the strain(s) of interest, providing the contact information requested, and then clicking the "Submit" button. This information will allow us to anticipate demand, optimize the availability levels for the strains and notify you when the strain(s) becomes available.

For additional questions please contact Dr. Beth Bauer at BauerBe@missouri.edu or phone (800) 669-0825 (in USA or Canada) or (573) 882-6459 (international calls).


Accepted Strains Interest Form

SelectStock #Mutation Type(s)Strain NameGene(s)Application(s)Reference(s)
RRRC:0284 Inbred strain ACI/EurMcwi Resistant to renal disease
  • Van Dijk SJ, Specht PA, Lazar J, Jacob HJ, Provoost AP.Renal damage susceptibility and autoregulation in RF-1 and RF-5 congenic rats. Nephron Exp Nephrol. 2005;101(2):e59-66.

  • RRRC:0304 GEPR-9
  • Yan QS, Dailey JW, Steenbergen JL, Jobe PC. Anticonvulsant effect of enhancement of noradrenergic transmission in the superior colliculus in genetically epilepsy-prone rats (GEPRs): a microinjection study. Brain Res. 1998 Jan 12;780(2):199-209.

  • RRRC:0322 Citron Kinase fh/+
  • Sarkisian MR, Rattan S, D'Mello SR, LoTurco JJ. Characterization of seizures in the flathead rat: a new genetic model of epilepsy in early postnatal development. Epilepsia. 1999 Apr;40(4):394-400.

  • Cogswell CA, Sarkisian MR, Leung V, Patel R, D'Mello SR, LoTurco JJ. A gene essential to brain growth and development maps to the distal arm of rat chromosome 12. Neurosci Lett. 1998 Jul 17;251(1):5-8.

  • Sarkisian MR, Li W, Di Cunto F, D'Mello SR, LoTurco JJ. Citron-kinase, a protein essential to cytokinesis in neuronal progenitors, is deleted in the flathead mutant rat. J Neurosci. 2002 Apr 15;22(8):RC217. Epub 2002 Apr 2.

  • RRRC:0366 HiS
  • Carroll ME, Morgan AD, Anker JJ, Perry JL, Dess NK. Selective breeding for differential saccharin intake as an animal model of drug abuse. Behav Pharmacol. 2008 Sep;19(5-6):435-60
  • RRRC:0393 LH-13BN
  • Gilibert S, Bataillard A, Nussberger J, Sassard J, Kwitek AE. Implication of chromosome 13 on hypertension and associated disorders in Lyon hypertensive rats. J Hypertens. 2009 Jun;27(6):1186-93.

  • RRRC:0394 LH-17BN
  • Gilibert S, Kwitek AE, Hubner N, Tschannen M, Jacob HJ, Sassard J, Bataillard A. Effects of chromosome 17 on features of the metabolic syndrome in the Lyon hypertensive rat. Physiol Genomics. 2008 Apr 22;33(2):212-7. Epub 2008 Feb 19

  • RRRC:0395 BN-13LH
  • Gilibert S, Bataillard A, Nussberger J, Sassard J, Kwitek AE. Implication of chromosome 13 on hypertension and associated disorders in Lyon hypertensive rats. J Hypertens. 2009 Jun;27(6):1186-93.

  • RRRC:0396 BN-2LH
    RRRC:0398 induced mutation FHH-Agtr1am1/Mcwi Agtr1a
  • Smits BM, Mudde JB, van de Belt J, Verheul M, Olivier J, Homberg J, Guryev V, Cools AR, Ellenbroek BA, Plasterk RH, Cuppen E. Generation of gene knockouts and mutant models in the laboratory rat by ENU-driven target-selected mutagenesis.Pharmacogenet Genomics. 2006 Mar;16(3):159-69.

  • RRRC:0427 Transgenic SD-Tg(Aqp5-GFP)Rrrc Aquaporin5 promoter controlling EGFP expression Salivary gland research:acinar cell labeling; Lung research: AT1 cell labeling
    RRRC:0440 LoS
  • Carroll ME, Morgan AD, Anker JJ, Perry JL, Dess NK. Selective breeding for differential saccharin intake as an animal model of drug abuse. Behav Pharmacol. 2008 Sep;19(5-6):435-60
  • RRRC: 0444 COP.DA(chr 16)
  • Ways JA, Smith BM, Barbato JC, Ramdath RS, Pettee KM, DeRaedt SJ, Allison DC, Koch LG, Lee SJ, Cicila GT. Congenic strains confirm aerobic running capacity quantitative trait loci on rat chromosome 16 and identify possible intermediate phenotypes. Physiol Genomics. 2007 Mar 14;29(1):91-7. Epub 2006 Dec 19.



  • Please Enter Contact Information
    (* = required field)
    Name: *
    Institution/Company: *
    Address:
     
    City:
    State/Province:
    Zip/Postal Code:
    Country:
    Phone: *
    Fax:
    E-mail: *
    Comments/Interests: